138 related articles for article (PubMed ID: 34282256)
1. Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast.
Gong P; Xia C; Yang Y; Lei W; Yang W; Yu J; Ji Y; Ren L; Ye F
Sci Rep; 2021 Jul; 11(1):14738. PubMed ID: 34282256
[TBL] [Abstract][Full Text] [Related]
2. Secretory Carcinoma of Breast: A Population-Based Study.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Feb; 90(2):252-260. PubMed ID: 37648259
[TBL] [Abstract][Full Text] [Related]
3. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.
Horowitz DP; Sharma CS; Connolly E; Gidea-Addeo D; Deutsch I
Breast; 2012 Jun; 21(3):350-3. PubMed ID: 22494666
[TBL] [Abstract][Full Text] [Related]
4. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
5. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
7. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
Jacob JD; Hodge C; Franko J; Pezzi CM; Goldman CD; Klimberg VS
J Surg Oncol; 2016 Jun; 113(7):721-5. PubMed ID: 27040042
[TBL] [Abstract][Full Text] [Related]
8. Secretory carcinoma of breast: clinicopathologic study of 8 cases.
Din NU; Idrees R; Fatima S; Kayani N
Ann Diagn Pathol; 2013 Feb; 17(1):54-7. PubMed ID: 22832018
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
[TBL] [Abstract][Full Text] [Related]
10. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract][Full Text] [Related]
11. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract][Full Text] [Related]
13. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
15. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
16. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
17. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.
Hoda RS; Brogi E; Pareja F; Nanjangud G; Murray MP; Weigelt B; Reis-Filho JS; Wen HY
Histopathology; 2019 Aug; 75(2):213-224. PubMed ID: 31012486
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy.
Escott CE; Zaenger D; Switchencko JM; Lin JY; Abugideiri M; Arciero CA; Pfister NT; Xu KM; Meisel JL; Subhedar P; Torres M; Curran WJ; Patel PR
Clin Breast Cancer; 2020 Dec; 20(6):e701-e710. PubMed ID: 32665190
[TBL] [Abstract][Full Text] [Related]
19. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).
Murthy V; Pawar S; Chamberlain RS
Clin Breast Cancer; 2017 Aug; 17(5):392-398. PubMed ID: 28602452
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
Li Z; Tu Y; Wu Q; Wang Z; Li J; Zhang Y; Sun S
Clin Breast Cancer; 2020 Apr; 20(2):e151-e163. PubMed ID: 31551181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
